Cerebellum’s iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019 VXZ Stock Holding History

Cerebellum’s Portfolio VXZ Stock Details VXZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-752	Closed	-$13K	–	575
2018 Q3	$13K	Sell	752 -66	-8%	-$1.17K	0.02%	371
2018 Q2	$16K	Buy	+818	New	+$16K	0.03%	365

Other funds holding VXZ

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Cerebellum's VXZ Position: Q4 2018 in Review

Cerebellum sold out of iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019 (VXZ) in Q4 2018, closing a stake of 752 shares — an estimated $13K sold.

Cerebellum first reported a position in VXZ in Q2 2018 and held it in 2 quarters. The position peaked at $16K in Q2 2018. 9 funds tracked by Wall St. Rank hold VXZ as of Q4 2018.

Cerebellum reported no remaining iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019 position as of Q4 2018 after selling out during the quarter.
Cerebellum sold 752 iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019 shares in Q4 2018, an estimated $13K.
Cerebellum first reported a position in iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019 in Q2 2018 and held it in 2 quarters.
Cerebellum's iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019 position peaked at $16K in Q2 2018.
9 funds tracked by Wall St. Rank held iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019 as of Q4 2018.

Based on Cerebellum's 13F filing for Q4 2018, filed 10 Jan 2019.